Jaguar Health Inc at Ladenburg Thalmann R&D Webinar Transcript
Hello, and welcome to Ladenburg Thalmann R&D Showcase. Our showcase is designed to highlight company products in the clinical or regulatory process. Today, we are excited to highlight Jaguar Health, and we'll turn it over to management in a moment.
We would first like to bring your attention to our necessary disclosures. Further, we would like to reiterate this webinar is being recorded, and intended for the investment community. We'd also like to note the risks associated with owning shares of Jaguar Health. If you have any questions or concerns, please contact me, Destiny Hance at [email protected].
Without further ado, I will turn it over to Jeffrey Cohen, Managing Director, Equity Research. Jeff?
Thank you, Destiny, and thank you, everyone for joining us. Today, we're going to be speaking with both Lisa Conte, CEO of Jaguar Health; as well as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |